Skip Nav Destination
Issues
1 September 2006
-
Cover Image
Cover Image
Cytotoxic agents in use for treatment of cancer may also display antiangiogenic effects, but the underlying mechanism is poorly understood. At equitoxic concentrations that do not inhibit cell proliferation, microtubule-targeting agents docetaxel, epothilone B and vinblastine, clearly abrogate human umbilical vein endothelial cell migration, invasion and organization to tubelike structures. In contrast, endothelial cell motility upon treatment with cisplatin or doxorubicin ressembles that of untreated cells. Microtubule-targeting agents affect the integrity of the tubulin and the actin cytoskeleton. Live image fluorescence microscopy shows that less F-actin stress fibers (in red) are formed and F-actin rings appear around the nucleus (in blue). The arrows point towards the direction of supposed cell movement. The disorganization of the actin cytoskeleton is associated with early inhibition of Rac1 and Cdc42 activity, being Rho GTPases that tightly coordinate cell motility. For details, see Bijman et al. in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Review
Research Articles: Therapeutics
A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells
Alison J. Butt; Caroline G. Roberts; Alan A. Seawright; Peter B. Oelrichs; John K. MacLeod; Tracy Y.E. Liaw; Maria Kavallaris; Tiffany J. Somers-Edgar; Gillian M. Lehrbach; Colin K. Watts; Robert L. Sutherland
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways
Chunrong Yu; Bret B. Friday; Jin-Ping Lai; Lin Yang; Jann Sarkaria; Neil E. Kay; Christopher A. Carter; Lewis R. Roberts; Scott H. Kaufmann; Alex A. Adjei
Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1
Giuliana Cassinelli; Cinzia Lanzi; Giovanna Petrangolini; Monica Tortoreto; Graziella Pratesi; Giuditta Cuccuru; Diletta Laccabue; Rosanna Supino; Sara Belluco; Enrica Favini; Anna Poletti; Franco Zunino
Research Articles: Targets
Research Article: Development
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.